COMPANY
ProRx LLC
ProRx LLC: warning letter recipient, recalling firm for Semaglutide, Tirzepatide, as stated by public registers.
Also written as: ProRx, LLC.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | Compounding Pharmacy/Adulterated Drug Products, 2025-03-04 Regulator FDA warning letters |
|---|---|
| Semaglutide | Compounding Pharmacy/Adulterated Drug Products, 2026-04-07 Regulator FDA warning letters |
| Tirzepatide | Compounding Pharmacy/Adulterated Drug Products, 2025-03-04 Regulator FDA warning letters |
| Tirzepatide | Compounding Pharmacy/Adulterated Drug Products, 2026-04-07 Regulator FDA warning letters |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Semaglutide | Class II recall, Ongoing, 2024-09-11 Regulator openFDA |
|---|---|
| Semaglutide | Class II recall, Ongoing, 2025-11-05 Regulator openFDA |
| Tirzepatide | Class II recall, Ongoing, 2024-09-11 Regulator openFDA |
| Tirzepatide | Class II recall, Ongoing, 2025-11-05 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.